Medical and Pharmaceutical Industries
NanoHorizons was founded in 2002 by a team of scientists from The Pennsylvania State University as part of the Centre County Industrial Development Corporation (IDC) incubator program. The company's mission was to develop and commercialize nanomaterial-enabled products based upon an extensive intellectual property portfolio. The early work of the company included the development of high performance flexible electronics, and nanomaterial-based sensors and analytical chemistry devices for drug discovery.
Selecta Biosciences is a clinical-stage biotechnology company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications.
Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications with the potential for improved efficacy and safety profiles.